Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses —8.57 B28.25 B— — Research & development ———— — Operating income 0-228.7 M-272.74 M-685.34 M -1.19 B Non-Operating Income, Total —124.23 M957 K— — Interest expense, net of interest capitalized —14.24 M14.41 M— — Non-Operating Income, excl. Interest Expenses —109.07 M-14.41 M— — Unusual income/expense —918 K957 K— — Pretax income 042.16 M545.2 M-316.68 M 270.68 M Equity in earnings ———— — Taxes 011.47 M40.15 M-22.29 M 29.33 M Non-controlling/minority interest —54.7 M—— — After tax other income/expense ———— — Net income before discontinued operations 030.69 M505.06 M-294.4 M 241.35 M Discontinued operations ———— — Net income 030.69 M505.06 M-294.4 M 241.35 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 030.69 M223.16 M-294.4 M -40.55 M Basic earnings per share (Basic EPS) —0.11.19— — Diluted earnings per share (Diluted EPS) —0.081.01-0.8 — Average basic shares outstanding —135.53 M174.71 M159.2 M — Diluted shares outstanding —143.1 M221.46 M366.48 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) —7.46 M7.4 M— —